The microRNA Let-7 and its exosomal form: Epigenetic regulators of gynecological cancers

Fei Wang1, Chundi Zhou1, Yanping Zhu2

  • 1Haiyan People's Hospital, Zhejiang Province, Jiaxing, 314300, Zhejiang, China.

PubMed

Insights

Gynecological cancers (GC) are often diagnosed late. Enhancing let-7 microRNA (miRNA) levels, potentially via exosomes, may offer a new diagnostic and therapeutic strategy for these challenging malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Gynecological cancers (GC) frequently present at advanced stages, complicating treatment and necessitating improved diagnostic and therapeutic approaches.
  • MicroRNAs (miRNAs) are key regulators of gene expression, and their dysregulation, particularly downregulation, is implicated in various human cancers.
  • The let-7 miRNA family plays a crucial role in cellular processes, and its reduced expression in certain cancers suggests therapeutic potential.

Purpose of the Study:

  • To explore the role of microRNAs, specifically let-7, in the development and progression of gynecological cancers.
  • To investigate the potential of targeting let-7 miRNA for diagnostic and therapeutic applications in gynecological cancer management.
  • To understand the involvement of exosomes in delivering miRNAs and influencing gynecological cancer hallmarks.

Main Methods:

  • Review of current literature on microRNA function in cancer.
  • Analysis of studies investigating let-7 miRNA expression in gynecological malignancies.
  • Examination of research on exosome biology and their role in intercellular communication and cancer progression.

Main Results:

  • Downregulation of specific miRNAs, including let-7, is a common feature in human cancers, including gynecological cancers.
  • Restoring let-7 miRNA expression is hypothesized as a potential therapeutic strategy for cancers where it is downregulated.
  • Exosomes, which carry miRNAs, are implicated in promoting tumor growth, angiogenesis, chemoresistance, metastasis, and immune evasion in gynecological cancer.

Conclusions:

  • MicroRNAs, particularly let-7, represent promising biomarkers and therapeutic targets for gynecological cancers.
  • Exosomes play a significant role in the intercellular communication and progression of gynecological cancers, offering avenues for novel treatment strategies.
  • Further research into miRNA-based therapies and exosome-mediated delivery systems is warranted for effective gynecological cancer management.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.0K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K